ABBOTT INDIA
Back to Balance Sheet
|
ABBOTT INDIA Last 5 Year Deferred Tax Assets / Liabilities History
[Standalone]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Deferred Tax Assets / Liabilities | ₹-26 Cr | ₹-15 Cr | ₹-16 Cr | ₹-17 Cr | ₹-17 Cr |
What is the latest Deferred Tax Assets / Liabilities ratio of ABBOTT INDIA ?
| Year | Deferred Tax Assets / Liabilities |
|---|---|
| Mar2026 | ₹-26 Cr |
| Mar2025 | ₹-15 Cr |
| Mar2024 | ₹-16 Cr |
| Mar2023 | ₹-17 Cr |
| Mar2022 | ₹-17 Cr |
How is Deferred Tax Assets / Liabilities of ABBOTT INDIA Trending?
| Years | Deferred Tax Assets / Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹-26 Cr | Negative | |
| Mar2025 | ₹-15 Cr | Negative | |
| Mar2024 | ₹-16 Cr | Negative | |
| Mar2023 | ₹-17 Cr | Negative | |
| Mar2022 | ₹-17 Cr | - | |
Compare Deferred Tax Assets / Liabilities of peers of ABBOTT INDIA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ABBOTT INDIA | ₹55,304.9 Cr | -3.9% | 0.1% | -10.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹427,861.0 Cr | -2% | -6.1% | 12.9% | Stock Analytics | |
| DIVIS LABORATORIES | ₹254,319.0 Cr | 3.2% | 5.3% | 67.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹179,153.0 Cr | -1.9% | -2.9% | 32.7% | Stock Analytics | |
| CIPLA | ₹107,406.0 Cr | -1.5% | -4% | -10.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹100,362.0 Cr | -2.7% | 4.2% | -1.2% | Stock Analytics | |
ABBOTT INDIA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ABBOTT INDIA | -3.9% |
0.1% |
-10.8% |
| SENSEX | 0.2% |
-4.6% |
-9.6% |
You may also like the below Video Courses